ChromaDex Corporation Reports First Quarter 2024 Financial Results
ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the first quarter of 2024.
- ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the first quarter of 2024.
- Net loss was $0.5 million or $(0.01) per share, a $1.4 million improvement, or $0.02 per share, from the prior year quarter.
- Adjusted EBITDA, a non-GAAP measure, improved to a positive $0.7 million from a negative $0.1 million in the prior year quarter.
- In April 2024, ChromaDex expanded distribution of Tru Niagen®, announcing partnerships with The Vitamin Shoppe and Sprouts Farmers Market, both targeting health-conscious consumers.